Brief: Elicera Therapeutics Q1 Operating Loss Widens To SEK 4.7 Mln

Elicera Therapeutics AB

26/04/2022 07:21

April 26 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ELICERA THERAPEUTICS AB (PUBL) INTERIM REPORT 1 JANUARY -
31
MARCH 2022
    * Q1 OPERATING PROFIT/LOSS TOTALED SEK -4,741,051
(-2,404,551)
    * Q1 LOSS FOR PERIOD TOTALED SEK -4,754,615 (-2,404,489)

Source text for Eikon:  ID:nWkrbNVZ9n 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))